Express News | James I. Healy Reports 5.5% Stake in Rapport Therapeutics Inc as of June 10, 2024- SEC Filing

BreakingsJun 15 04:02

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement

BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational sma

GlobeNewswireJun 13 04:01

Rapport Therapeutics Starts Trading Above IPO Price

Seeking AlphaJun 8 00:04

Express News | Rapport Therapeutics stocks opened at $18 on the first day of trading on Nasdaq, higher than the offering price of $17 per share.

BreakingsJun 7 23:10

Express News | Rapport Therapeutics Shares Open at $18 in Nasdaq Debut Vs IPO Price of $17 per Share

BreakingsJun 7 23:09

Rapport Therapeutics IPO Price Indicating $18 On 196,335 Shares; IPO Priced At $17 On 8M Shares

Rapport Therapeutics IPO Price Indicating $18 On 196,335 Shares; IPO Priced At $17 On 8M Shares

BenzingaJun 7 22:33